Partner
CurrentI represent clients in high-stakes patent infringement lawsuits. Serving as first-chair trial counsel, I won an $80-million judgment on behalf of Amgen in Amgen v. Hospira, the first patent-infringement jury trial about a biosimilar under the BPCIA. In 2019, I won affirmance of that judgment on appeal to the U.S. Court of Appeals for the Federal Circuit, where I served as lead counsel for Amgen. LMG Life Sciences recognized the case as a Patent Impact Case of the Year for 2017. I also represented Onyx Therapeutics at trial in 2019 in a case about Onyx’s Kyprolis® (carfilzomib) medicine.I've been recognized as a leader in patent litigation. The National Law Journal named me to the 2019 "Intellectual Property Trailblazer" list. In 2018, I was recognized as the “General Patent Litigator of the Year – Illinois” at the sixth annual LMG Life Sciences Awards. I have also been recognized on the IAM Patent 1000 list of leading patent professionals, as an “IP Star” in Managing IP’s IP Stars Survey, as an Illinois Super Lawyer for intellectual property litigation by Super Lawyers Magazine, as a "Life Sciences Star" in LMG Life Sciences, and as a “Leading Lawyer” by Leading Lawyers, a division of Law Bulletin Publishing Company.